The immunohistochemical expression of c-MET and RON in lung adenocarcinoma with clinicopathologic correlation

被引:1
|
作者
Kim, Young-Ah [1 ,2 ]
Sung, Woo Jung [1 ]
机构
[1] Daegu Catholic Univ, Dept Pathol, Sch Med, Duryugongwon ro 17 gil 33, Daegu 42472, South Korea
[2] Seoul Clin Labs Daegu, 95 Hwarang ro, Daegu 41238, South Korea
关键词
c-MET; lung adenocarcinoma; non-small cell lung cancer; RON; RECEPTOR TYROSINE KINASE; COPY NUMBER; CANCER; AMPLIFICATION; OVEREXPRESSION; PROGRESSION; ACTIVATION; RESISTANCE; GEFITINIB; PATHWAY;
D O I
10.4103/ijpm.ijpm_358_22
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Background:Mesenchymal epidermal transition (MET) and receptor originating from nantes (RON) are transmembrane tyrosine kinase receptors. Both are members of a proto-oncogene family and thus play a role in the pathogenesis of various cancers and acquired resistance to kinase inhibitors in lung cancer.Aims:The aim of this study was to investigate the immunohistochemical expression of c-MET and RON in lung adenocarcinoma and its clinicopathologic correlation.Settings and Design:Retrospective study.Materials and Methods:The immunohistochemical c-MET and RON expression in specimens obtained from lung adenocarcinoma (n = 175) and associated clinicopathologic parameters were evaluated.Statistical Analysis Used:The correlation between c-MET and RON expression was analyzed by Chi-square test. A Cox proportional hazards model and Kaplan-Meier curve analysis were used to evaluate the risk factors and prognosis.Results:High expression of the c-MET protein showed a strong correlation with that of RON (P = 0.013, kappa = 0.183). Five-year survival and recurrence-free 5-year survival were not associated with high expression of c-MET or RON. High c-MET expression was significantly associated with age older than 60 years (P = 0.000), tumor differentiation (P = 0.009), lymphovascular invasion (P = 0.016), and pleural invasion (P = 0.005). High RON expression was associated with a solid growth pattern (P = 0.001) and pleural invasion (P = 0.002).Conclusions:The results point to the potential of immunohistochemical expression of c-MET and RON as useful prognostic markers of unfavorable histopathologic features in lung adenocarcinoma.
引用
收藏
页码:23 / 29
页数:7
相关论文
共 50 条
  • [21] Immunohistochemical evaluation of glutaminase expression in prostate adenocarcinoma and correlation with clinicopathologic parameters.
    Myint, Zin
    Hensley, Patrick J.
    James, Andrew Callaway
    Wang Peng
    Strup, Stephen
    Yan Donglin
    St Clair, William H.
    DiPaola, Robert S.
    Allison, Derek B.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [22] Expression of Receptor Tyrosine Kinases RON and c-Met in Post-Transplant Lymphoproliferative Disorders
    Wey, E.
    Keyoumarsi, F.
    Smith, L.
    Thomas, D.
    Elenitoba-Johnson, K.
    Lim, M.
    LABORATORY INVESTIGATION, 2012, 92 : 380A - 381A
  • [23] c-Met expression in hemangioblastomas
    Revercomb, Carolyn H.
    Zagzag, David
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2007, 66 (05): : 442 - 442
  • [24] c-Met expression in hemangioblastomas
    Revercomb, Carolyn H.
    Zagzag, David
    FASEB JOURNAL, 2007, 21 (05): : A392 - A392
  • [25] Expression of Receptor Tyrosine Kinases RON and c-Met in Post-Transplant Lymphoproliferative Disorders
    Wey, E.
    Keyoumarsi, F.
    Smith, L.
    Thomas, D.
    Elenitoba-Johnson, K.
    Lim, M.
    MODERN PATHOLOGY, 2012, 25 : 380A - 381A
  • [26] Constitutive activation of c-Met is correlated with c-Met overexpression and dependent on cell-matrix adhesion in lung adenocarcinoma cell lines
    Nakamura, Yu
    Matsubara, Daisuke
    Goto, Akiteru
    Ota, Satoshi
    Sachiko, Oguni
    Ishikawa, Shumpei
    Aburatani, Hiroyuki
    Miyazawa, Keiji
    Fukayama, Masashi
    Niki, Toshiro
    CANCER SCIENCE, 2008, 99 (01) : 14 - 22
  • [27] Lung adenocarcinoma with MET exon 14 skipping mutation; clinicopathological characteristics and immunohistochemical MET expression
    Motoi, Noriko
    Sunami, Kuniko
    Ohe, Yuichiro
    Watanabe, Shun-ichi
    Kohno, Takashi
    LABORATORY INVESTIGATION, 2018, 98 : 742 - 742
  • [28] Lung adenocarcinoma with MET exon 14 skipping mutation; clinicopathological characteristics and immunohistochemical MET expression
    Motoi, Noriko
    Sunami, Kuniko
    Ohe, Yuichiro
    Watanabe, Shun-ichi
    Kohno, Takashi
    MODERN PATHOLOGY, 2018, 31 : 742 - 742
  • [29] The immunohistochemical expression of c-Met is an independent predictor of survival in patients with glioblastoma multiforme
    Olmez, O. F.
    Cubukcu, E.
    Evrensel, T.
    Kurt, M.
    Avci, N.
    Tolunay, S.
    Bekar, A.
    Deligonul, A.
    Hartavi, M.
    Alkis, N.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S793 - S793
  • [30] c-MET immunohistochemical expression in sporadic and inflammatory bowel disease associated lesions
    Grant Halliday
    Ross J Porter
    Catherine J Black
    Mark J Arends
    Shahida Din
    World Journal of Gastroenterology, 2022, (13) : 1338 - 1346